Intellectual Asset Management

Intellectual Property Management and intellectual asset management advice for investors, patent counsel and corporate IP managers.

Illumina and Sequenom pool noninvasive prenatal testing IP

Illumina will have exclusive worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents

December 4, 2014

1 2 3 53